DAEWOONG PHARMACEUTICAL CO., LTD.;THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
发明人:
KIM HEE SUN,김희선,SHIN HYUN JU,신현주,KIM CHANG WOOK,김창욱
申请号：
KR1020170152276
公开号：
KR1018875610000B1
申请日:
2017.11.15
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention provides a pharmaceutical composition for alleviating hepatic fibrosis induced by hepatitis virus, which comprises ursodeoxycholic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The composition of the present invention can effectively prevent progression to a hepatic cirrhosis step.본 발명은 우르소데옥시콜산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는, 간염 바이러스에 의해 유발된 간 섬유화의 개선을 위한 약학 조성물을 제공한다.
